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Abstract: Oxidant molecules generated during neuronal metabolism appear to play a significant role in the processes of 
aging and neurodegeneration. Increasing experimental evidence suggests the noteworthy relevance of the intracellular 
reduction-oxidation (redox) balance for the dopaminergic (DA-ergic) neurons of the substantia nigra pars compacta. 
These cells possess a distinct physiology intrinsically associated with elevated reactive oxygen species production, 
conferring on them a high vulnerability to free radical damage, one of the major causes of selective DA-ergic neuron 
dysfunction and degeneration related to neurological disorders such as Parkinson’s disease. Tyrosine hydroxylase 
(tyrosine 3-monooxygenase; E.C. 1.14.16.2; TH) activity represents the rate-limiting biochemical event in DA synthesis. 
TH activity, metabolism and expression are finely tuned by several regulatory systems in order to maintain a crucial 
physiological condition in which DA synthesis is closely coupled to its secretion. Alterations of these regulatory systems 
of TH functions have indeed been thought to be key events in the DA-ergic degeneration. TH has seven cysteine residues 
presenting thiols. Depending on the oxido-reductive (redox) status of the cellular environment, thiols exist either in the 
reduced form of free thiols or oxidized to disulfides. The formation of disulfides in proteins exerts critical regulatory 
functions both in physiological and in pathological conditions when oxidative stress is sustained. Several reports have 
recently shown that redox state changes of thiol residues, as consequence of an oxidative injury, can directly or indirectly 
affect the TH activity, metabolism and expression. 
The major focus of this review, therefore, is to report recent evidence on the redox modulation of TH activity and 
expression, and to provide an overview of a cellular phenomenon that might represent a target for new therapeutic 
strategies against the DA-ergic neurodegenerative disorders. 
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INTRODUCTION 
 The major biochemical processes are characterized by 
fluxes of electrons between molecules: an oxidized donor 
and a reduced acceptor. Flux occurs spontaneously from 
more negative potential to less negative ones; thus, electrons 
travel in a preferential direction. As a direct consequence, the 
cellular environment has a natural tendency to oxidize. This 
physiological trend towards oxidation is counterbalanced and 
finely tuned by the enzymatic and non-enzymatic activity of 
antioxidant species to maintain the redox homeostasis. The 
redox balance relies mostly on the thiol groups of cysteine 
(Cys) residues. Thiol groups are particularly sensitive to 
variations in the redox environment, since they can be  
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readily oxidized to disulfides. This reversible electron-
exchange and non-enzymatic reaction constitutes an early 
response to buffer alterations in the redox homeostasis [1]. 
 Reuced glutathione (GSH) and thioredoxins, two 
molecules specialized in the control of the redox state, 
constitute the major non-enzymatic/enzymatic cellular redox 
buffers. Moreover, other proteins or enzymes can participate 
in redox control, and constitute the protein thiol pool [2, 3]. 
Besides contributing to redox regulation, oxidation of Cys in 
the protein thiol pool can have other important effects. Thiol 
redox changes, indeed, can be protective, preventing higher 
forms of oxidation, such as the formation of sulfenic acid, an 
irreversible, two-electron oxidation of Cys residues [1]. 
Irreversible oxidation of proteins can change their physical 
properties, promoting events such as aggregation, and can 
alter protein function, either providing new functions (gain 
of function) or reducing the normal one (loss of function) [4, 
5]. 
 If under any circumstance the redox balance is altered in 
favour of the pro-oxidant events, the state is defined as 
oxidative stress. The increase in the production of reactive 
oxygen species (ROS) will generate an abnormal flux of 
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electrons, which will overwhelm the cellular buffering 
systems (GSH, thioredoxins) and the protein thiol pool. 
Therefore, a variety of molecular species such as DNA, 
membrane lipids and protein structure and functions will be 
affected [6, 7] causing cellular dysfunction and damage (Fig. 
1). 
 The brain is particularly susceptible to oxidative stress 
because it utilizes the highest amount of oxygen compared 
with other organs. The brain also contains high 
concentrations of polyunsaturated fatty acids that are prone 
to lipid peroxidation and is rich in iron, which can catalyse 
hydroxyl radical formation [8-10]. Oxidative stress results in 
functional cellular disruption and cellular damage and may 
cause subsequent cell death via oxidation of biomolecules 
such as proteins, lipids, and nucleic acids. Protein oxidation 
leads to functional changes or deactivation of various 
enzymes [6]. Lipid peroxidation causes membrane structure 
alterations that affect membrane fluidity and permeability 
and membrane protein activity [7]. Oxidative stress is 
involved in normal conditions such as aging processes and in 
the pathogenesis of a number of neurologic and 
neurodegenerative disorders, including Alzheimer’s disease 
and Parkinson’s disease (PD), amyotrophic lateral sclerosis 
and epilepsy [11-15]. 
 Dopamine (DA) neurons in the substantia nigra pars 
compacta (SNc) selectively degenerate in PD [15-17]. Their 
particular physiology is intrinsically associated with elevated 
ROS production. DA neurons are spontaneous pacemaking 
cells, and generate rhythmic action potentials in the absence 
of synaptic inputs. While most neuronal types use Na+ to 
generate their action potentials, SNc DA neurons rely on 
Ca
2+
, which enters the cytoplasm through L-type channels 
[18-20]. Over time, the spontaneous activity of these neurons 
could lead to elevated and harmful concentrations of 
cytosolic Ca
2+
. This potential harm can be prevented by the 
buffering activity of certain organelles, such as 
mitochondria. However, this activity is invariably associated 
with ROS production [21, 22]. In addition, excess ROS 
could derive directly from DA metabolism, which generates 
harmful by-products such as semiquinones and hydrogen 
peroxide [23]. The overall result is an increase in the basal 
levels of ROS in SNc DA neurons that impairs their ability 
to tolerate further oxidative insults. In fact, systemic 
administrations of pro-oxidants, which target every cell in 
the brain, results in selective damage of the DA system, and 
chronic administration of ROS producers, such as rotenone, 
6-hydroxydopamine and paraquat, mimic PD pathogenesis 
[24-26]. DA release is constantly accompanied by a 
concomitant increase in the rate of DA synthesis [27]. 
 Tyrosine hydroxylase (TH) is the first and rate-limiting 
enzyme in DA synthesis through the reaction of 
hydroxylation of L-tyrosine to L-3,4-dihydroxy-
phenylalanine (L-DOPA). TH activity is mainly modulated 
by phosphorylation at serine residues (Ser) Ser8, Ser19, 
Ser31 and Ser40 [28] by a variety of protein kinases. TH 
belongs to a family of iron-containing, biopterin-dependent 
amino acid hydroxylases that use tetrahydrobiopterin (BH4) 
and O2 to hydroxylate L-tyrosine [29]. The Fe
2+
 is bound to 
TH and can be oxidized to Fe
3+
 in the presence of O2, 
forming bonds with catechols and enabling a feedback 
inhibitor process [30]. These two primary regulatory 
mechanisms of TH function can be strongly affected by 
changes redox state. 
 Peroxynitrite (ONOO
-
) is perhaps best known for its 
ability to nitrate free tyrosine or tyrosine residues in proteins 
[31]. ONOO
-
 has been implicated as an etiological factor in 
the DA neuronal degeneration associated with PD and in 
other neurodegenerative and neurotoxic conditions [32, 33]. 
Exposure of TH to ONOO
-
 inhibits its catalytic activity and 
results in extensive tyrosine nitration of the protein [34, 35]. 
However, ONOO
- 
is also a powerful oxidant. Interactions of 
ONOO
-
 with intracellular thiols could readily alter its 
reactive properties and in the process, create downstream 
reactants (e.g., S-nitrosothiols) that have equal potential to 
modify critical cellular proteins [36]. Phosphorylation of Ser 
residues on TH can differently affect not only the activity but 
also enzyme stability or its degradation [37]. Experimental 
evidence has demonstrated that oxidative stress can also 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Biological relevance of cellular redox status. The figure describes the physio-pathological events related to changes in redox 
balance. Slight increases of intracellular oxidation constitute reversible inputs leading to the activation of signal pathways necessary for the 
normal cell metabolism. Mild oxidative insult can be managed by cellular adaptive responses. A sustained or prolonged oxidative injury 
causes irreversible damage of biological molecules, cell dysfunction and death. The figure was kindly provided by PG Mastroberardino. 
Redox Sensitivity of Tyrosine Hydroxylase Activity and Expression CNS & Neurological Disorders - Drug Targets, 2012, Vol. 11, No. 4     421 
affect TH metabolism and turnover by affecting the 
mechanisms of Ser phosphorylation in TH [38, 39]. The 
main long-term regulatory mechanisms of TH activity rely 
on TH gene expression [30]. 
 The DA-ergic dysfunction in brain is always associated 
with a decrease of TH expression related to DA neuron loss, 
increase of TH degradation and altered gene regulation. 
Substantial evidence exists supporting the crucial role of 
oxidative injury in the alteration of TH gene expression. The 
redox-sensitive factors Zinc finger regulatory proteins [40], 
DJ-1 [41] and estrogen exposure [42] have been considered 
the major oxidative stress-related factors leading to altered 
expression of TH. 
 In this review, we will discuss the oxidative mechanisms 
of neurotoxicity in DA neurons, and provide an overview of 
the most relevant findings showing the biological relevance 
of oxidative stress-mediated TH activity, metabolism and 
expression mechanisms and their possible implications in the 
development of neurodegenerative disorders. 
OXIDATIVE STRESS AND DOPAMINERGIC 
DAMAGE 
 The brain is characterized by extraordinary functional 
complexity. It is likely that the intracellular redox state and 
its homeostasis differ among cell types. In this respect, 
recent in vitro and in vivo studies investigating the neuronal 
redox response, have shown that DA neurons are particularly 
vulnerable to pro-oxidant stimuli [21, 43], and under basal 
conditions, the intracellular redox state is more oxidized in 
DA neurons than in others [15, 44] (Fig. 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Intracellular redox state of DA-ergic neurons of the 
substantia nigra pars compacta (SNc) in normal rats. The basal 
intracellular redox state of DA neurons in the SNc is more oxidized 
than that of DA neurons of the ventral tegmental area (VTA) or 
cortical neurons. (From: Horowitz, Milanese Di Maio et al., 2011). 
This phenomenon finds an explanation in the particular biology of 
DA-ergic neurons of SNc. 
 This phenomenon observed in DA neurons of the SNc 
may be explained by their particular physiology. In fact, DA 
neurons do not require synaptic inputs since they are  
 
characterized by a spontaneous pacemaking activity, 
mediated by L-type Ca
2+ 
channels [19, 20] and each action 
potential is associated with a robust Ca
2+
 influx. The 
consequent increase of cytosolic Ca
2+
 concentration could 
constitute a harmful event for the cell. Under physiological 
conditions this phenomenon is prevented by extrusion 
mechanisms of Ca
2+
 and endoplasmic reticulum Ca
2+ 
uptake. 
This protective action is carried out as well by mitochondria. 
The Ca
2+
 influx into the mitochondrial matrix neutralizes the 
trans-membrane proton gradient, with a resultant increase in 
activity of respiratory complexes. Intrinsic to this process is 
an increased production of ROS. Over time, the continuous 
activity of DA neurons may lead to increased ROS levels 
and thus to a more oxidized intracellular redox state. The 
mitochondrial physiology, influenced by a particular use of 
Ca
2+
, could also provide a partial explanation for the 
amplified response observed in DA neurons exposed to 
toxicants causing mitochondrial impaired function, when 
compared to cortical neurons. 
 The redox state of thiols exerts a profound effect on the 
physiology of neurons; for instance, it regulates fundamental 
processes such as synaptic plasticity [45] and controls the 
conductance of several ion channels involved in neuronal 
excitability [46, 47]. Additionally, thiol oxidation has been 
involved in zinc finger transcription factor activity [48], 
transferrin mediated iron accumulation [49], and decrease of 
TH activity [36]. 
 Cysteine residues control the redox environment through 
reversible oxidation of thiols to disulfides. As oxidative 
stress increases, a high number of Cys in the protein thiol 
pool will be oxidized to disulfides. The reversible conversion 
of thiols to disulfides is one the earliest observable events 
during radical-mediated oxidation of proteins [50, 51]. Thiol 
oxidation has functional consequences as it may be 
correlated to protein inactivation [1]. As the oxidative 
imbalance increases, amino acids other than Cys can be 
irreversibly oxidized; many of these modifications require 
more persistent oxidant conditions than disulfide formation 
[1]. Among the possible modifications, formation of 
carbonyls, which occurs especially on the side chains of Lys, 
Arg, Pro and Val, is the most extensively studied [1]. 
Carbonyl formation has been detected in DA-ergic 
dysfunctions induced by toxicants [52, 53]. Carbonyl 
formation can be induced by different oxidizing agents and 
often results in loss of protein function [54]. Carbonyls are 
relatively difficult to induce compared to Cys oxidation and 
indeed, high carbonyl levels tend to indicate that oxidative 
stress is already associated with some kind of disease related 
dysfunction [55, 56]. 
 A further set of oxidative modifications that can affect 
proteins derives from the interaction of nitric oxide with 
molecular oxygen to generate ONOO
-
 which, in turn, can 
react with some side chain amino acids, including tyrosines 
and Cys, to form respectively nitrotyrosine and 
nitrosocysteine. Importantly, neuronal inflammation related 
to pro-oxidant toxins involves the up-regulation of inducible 
nitric oxide synthese as well as activation of NADPH 
oxidases [16]. This sequence of events favours the 
production of ONOO
-
, which has been strongly implicated in 
the DA-ergic neurotoxicity in PD pathogenesis [57]. 
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REGULATION OF TH ACTIVITY 
 The active form of TH is a tetramer with a molar mass of 
approximately 240 kDa [30] with high homology in terms of 
sequence and catalytic mechanisms to phenylalanine 
hydroxylase and tryptophan hydroxylase (TPH). TH 
catalyses the initial and rate-limiting step in the biosynthesis 
of the catecholamines (CAs) DA, noradrenaline and 
adrenaline. In TH-mediated reaction, dioxygen, L-tyrosine, 
and BH4 are converted to L-DOPA and 4a-hydroxytetra-
hydrobiopterin (4aOH-BH4) [58]. Phosphorylation mechan-
isms are the primary biochemical events responsible for TH 
activation and CAs homeostasis maintenance in tissues. The 
regulation of TH activity is accomplished by dynamic 
changes in the phosphorylation state of the enzyme and four 
phosphorylation sites have been identified, Ser8, Ser19, 
Ser31, and Ser40 by a variety of protein kinases (Fig. 2). 
Each catalytically active subunit of all aromatic amino acid 
hydroxylases contains a single atom of non-heme iron. 
 The hydroxylation of L-tyrosine to L-DOPA catalysed by 
TH in the presence of BH4 and O2 requires the reduced status 
of the iron atom (Fe
2+
) in the catalytic site. Fe
2+ 
during the 
reaction becomes oxidized to Fe
3+
 by O2 and in this form, 
binds catechols to become inactive (Fig. 3). The chemical 
interaction of Fe
3+
-catechols represents the main mechanism 
of feedback leading to enzyme inactivation and stabilization 
under physiological conditions. Indeed, as a result of this 
reaction, TH activity is inhibited by a binding competition of 
catechols with BH4 for binding of the ferric iron at the 
catalytic site of the enzyme. This is a classic kinetic 
mediated, reversible inhibition and acts as a sensor of the 
local concentrations of the catechols. Furthermore, catechols 
can bind almost irreversibly with ferric iron at the TH 
catalytic site [30]. Phosphorylation mechanisms and 
catechol-mediated TH inhibition can interact to further 
modulate the enzyme activity. Phosphorylation of TH, 
indeed, alters the enzyme’s conformation leading to a form 
of TH that is still inhibited, but with an increased rate of 
dissociation of the bound CAs-Fe
3+
 [59]. Loss of CAs 
binding allows the Fe
3+
 to be reduced by BH4, thereby 
returning the enzyme to the fully active state. TH is subject 
to feedback inhibition by a range of catechols but the 
physiologically relevant CAs DA, noradrenaline and 
adrenaline all have the highest affinity [60]. The most likely 
candidates for the phosphorylation of Ser19, Ser31, and 
Ser40 are calcium/calmodulin-dependent protein kinase II, 
mitogen-activated protein kinase, and protein kinase A, 
respectively. The phosphorylation of Ser40 has the major 
effect on TH activity [37]. 
REDOX-MEDIATED MODULATION OF TH 
ACTIVITY
 DA neurons are particularly prone to damage caused by 
aging, neurological disease, drugs and environmental 
contaminants [61-63]. PD, for instance, is a neuro-
degenerative disorder characterized, in part, by the 
progressive and selective loss of DA-ergic neuron cell bodies 
within the SNc and the associated deficiency of DA in the 
striatum, which gives rise to the typical motor symptoms. 
Data from epidemiological studies in humans and molecular 
studies in genetic, as well as in toxin-induced animal models 
of PD, indicate that mitochondrial dysfunction and oxidative 
stress occurs early in the pathogenesis of this neuro-
degenerative disorder [64]. 
 Mechanistic studies carried out in the past years in 
different animal models of PD have increasingly focused on 
oxidative stress as crucial phenomenon in the DA 
dysfunction. More recently, it has become evident that TH 
function can be altered under conditions of oxidative and 
nitrosative stress through direct modification of the protein. 
ONOO
-
 inhibits TH catalytic function via a mechanism that 
involves nitration of tyrosine residues [35] or direct 
oxidation of Cys residues [65, 66]. 
 Carbonylation, sulfenic or sulfonic acid in proteins are 
related to irreversible structural and functional 
modifications, and represent a potentially harmful 
consequence of oxidative stress. Thiol-containing small 
molecules like Cys and GSH participate in cellular redox 
homeostasis by preventing oxidative modification of 
proteins. However, increasing evidence shows that Cys or 
GSH, under oxidative conditions, can covalently modify 
proteins by forming mixed disulfides with them, a 
phenomenon defined as S-thiolation. S-Thiolation is a 
dynamic regulatory mechanism that has many parallels with 
protein phosphorylation, and target-dependent functional 
consequences. The consequences of S-thiolation on a 
specific thiol residue in a specific protein are hard to predict, 
since it can be protective by masking of a critical Cys against 
irreversible oxidation or cause loss of function [67]. A 
growing number of proteins are now known to be modified 
by S-thiolation, including TH [36]. 
 ONOO
-
 is known to nitrate free tyrosine or tyrosine 
residues in proteins, and it has been implicated as an 
etiological factor in the DA neuronal degeneration associated 
with PD and in other neurodegenerative diseases [32]. 
Exposure of TH to ONOO
-
 inhibits its catalytic activity and 
results in extensive tyrosine nitration of the protein. 
Furthermore, given the pro-oxidant property of ONOO
-
, a 
recent study suggests that oxidized forms of Cys or GSH 
(e.g. GS (O) SG) are produced in the reaction with ONOO
- 
or NO2 and mediate S-thiolation of TH [36]. 
 The observation of elevated levels of nitrotyrosine in 
chronically affected tissues and the fact that DA neurons 
express factors able to prevent the ONOO
-
-mediated tyrosine 
nitration, including DA itself [66], the TH cofactor BH4 [68], 
and reduced nicotinamide nucleotides [69], support the 
hypothesis that nitrotyrosine formation represents a late 
event in the process of degeneration of these neurons and is 
not an early sign of distress or damage [70], whereas, Cys 
and GSH could be among the factors that prevent the 
ONOO
-
-induced tyrosine nitration by S-thiolation as a 
potential early response to stress. Experimental models of 
oxidative damage-mediated DA dysfunction have been 
invaluable to dissect the biochemical mechanisms of toxicity 
in DA-synthesizing cells. Increasing evidence obtained in 
toxin models of PD, for instance, provides an emerging 
emphasis on the crucial role of cellular oxidative injury on 
TH activity, an important aspect of PD pathogenesis [38, 39, 
71]. 
 Recent experimental evidence shows that treatment with 
potent pro-oxidants in different DA cells lines causes a 
sustained TH phosphorylation [39]. Particular emphasis has 
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been given to the mechanisms of phosphorylation of Ser 19, 
Ser 31 and Ser 40, for their crucial role in TH activity and 
metabolism. Recently, it was proposed that phosphorylation 
at Ser40 of TH is entirely routed by the cAMP-dependent 
kinase, phosphokinase A [72]. In support of the redox 
modulation of this pathway of TH phosphorylation at Ser40, 
a crucial regulatory event of TH activity, it has been shown 
that the oxidative injury induced by H2O2 and 1-methyl-4-
phenylpyridinium treatment in SH-SY5Y cells causes the 
TH phosphorylation at Ser40 via cAMP-dependent 
messenger cascades. This phenomenon was abolished by 
treatment with melatonin [38]. 
 Recently, abnormality of the degradation of intracellular 
proteins has been addressed as a major cause of 
neurodegeneration. DA-ergic dysfunctions are characterized 
by reduction of TH in DA neurons. For this reason, TH 
expression has been widely used as a marker of DA-ergic 
function. Studies aimed to assess the degradation mechanism 
regulating the protein level of TH, have highlighted the 
importance of phosphorylation at different Ser residues in 
stabilizing the enzyme [73]. However, some reports indicate 
that the phosphorylation of hydroxylases induces their 
degradation by proteasomes. For example, the 
phosphorylation of TPH is a prerequisite for the ubiquitin-
proteasome pathway activation leading to the degradation of 
TPH [74]. TH phosphorylated at its Ser40 is prone to be 
insoluble and aggregated by dysfunction of the ubiquitin-
proteasome pathway in PC12D cells [75]. 
 Thus, based on the fact that changes in intracellular redox 
status can affect directly the phosphorylation mechanisms at 
Ser40 of TH, it is possible to hypothesize that oxidative 
stress might influence TH metabolism causing short-term 
alterations of DA homeostasis in affected cells. 
 Thiol oxidation is the principal mechanism integrating 
intracellular redox state with signalling pathways [76]. 
Extracellular signal-regulated kinases 1/2 (ERK 1/2) is a 
member of the mitogen activated protein kinase pathway that 
is known to promote cell survival and is activated during 
redox imbalance [77]. Moreover, ERK 1/2 signalling is 
implicated in the phosphorylation of Ser31 of TH 
modulating its stability [37]. The evidence that, in a 
synchronized manner, cellular oxidation anticipates ERK 1/2 
phosphorylation with a consequent reduction of the cellular 
environment [44], and that the over-expression of TH 
improves the cellular resistance against cell death induced by 
oxidative stressors [71], supports the idea that TH activity 
and metabolism could contribute to the cellular redox 
homeostasis 
OXIDATIVE STRESS AND TH ACTIVITY IN AGING 
 Impaired function in the central nervous system during 
aging is accompanied by changes in various neurotransmitter 
systems [78, 79]. Decreases in DA content [80] and DA 
turnover [81] have been reported to occur during aging in the 
rat nigrostriatal system. The fact that such decrease in DA-
ergic metabolism could be accompanied by loss of nigral 
DA-ergic neurons during aging in mammals remains 
controversial, since contrasting data show no age-related 
changes in DA neurons in humans [82, 83]. The decrease of 
endogenous anti-oxidant defences and the oxidant molecules 
generated during normal metabolism appear to play a 
significant role in the processes of aging. Thus, the main 
mechanisms of alteration in DA-ergic functions might be 
related prevalently to the increase of oxidative damage. This 
hypothesis is further supported by the fact that aged animals 
are more susceptible to DA-related neurodegenerative 
disorders. Additionally, experimental evidence reports the 
ameliorative effect of the DA precursor, L-DOPA, in a toxin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Regulatory feedback mechanisms of TH activity (model of Ramsey and Fitzpatrick). The active form of TH contains reduced iron 
(Fe
2+
). A sustained production of catechol can induce inactivation by oxidation of the Fe
2+
 to Fe
3+
 and subsequent catechol binding or by 
binding to the substrate L-tyrosine at high concentrations. TH can be activated by protein phosphorylation and reduction of iron with 
tetrahydrobiopterin (BH4). 
424      CNS & Neurological Disorders - Drug Targets, 2012, Vol. 11, No. 4 Di Giovanni et al. 
model of PD developed in aged rats [84], suggesting that 
oxidative impairment of TH could be the determinant factor 
in the occurrence of the DA-ergic dysfunction in aging and 
as well as in DA dysfunctions. 
 A study conducted by De La Cruz et al. [63] showed that 
TH activity significantly decreases (55%) in rat brain SNc 
during aging. In particular, these findings describe a major 
role of oxidative damage in the accumulation of 
carbonylated inactive TH, more in SNc than in striatum of 
aged rat. This phenomenon occurring in SNc during aging 
provides further insights on the crucial role of TH in the 
higher vulnerability of DA neurons to oxidative damage. 
 In summary, DA-ergic oxidative damage in aging 
processes has some parallels to the pathogenesis of 
degenerative diseases affecting SNc, and has also been 
considered one of the most crucial para-physiological 
phenomena leading DA neurons to a status that is more 
prone to degeneration. 
OXIDATIVE STRESS AND TH EXPRESSION 
 Transcriptional regulation of the TH gene constitutes one 
of the main long-term regulatory mechanisms of TH 
expression. Thus, given the crucial role of intracellular redox 
status in modulating TH gene expression, neuronal oxidative 
injury can cause impairment in physiological levels of TH 
and the consequent DA dysfunction in aging and in 
neurodegenerative disorders involving the DA-ergic system. 
 Given its specific localization, TH is one of the main 
biomarkers used to assess the DA-ergic phenotype and 
function. Several recent studies have reported that 
antioxidant molecule treatment elicits recovery of TH 
expression in different models of DA-ergic dysfunction [85-
88]. Interestingly, for instance, antioxidant properties of 
lithium treatment in animal models of neurodegeneration 
have been reported [89-91]. Moreover, lithium treatment 
shows efficacy in increasing TH expression [92, 93]; 
however, this is still controversial [94]. Despite these latest 
findings, it is not yet known whether the anti-oxidant 
mechanisms enhanced by lithium administration are 
involved in the modulation of TH expression. TH down-
regulation is a common sign of DA-ergic degeneration and 
might be caused by both altered gene functions and 
neurotoxicity-mediated protein synthesis impairment. 
Oxidative stress occurring during DA-ergic 
neurodegeneration might specifically affect the molecular 
mechanisms of TH expression. Therefore, despite the 
increasing amount of experimental evidence in this research 
area, the biochemical mechanisms by which oxidative stress 
might directly affect TH expression remain underexplored. 
Additionally, the aforementioned findings do not provide 
further insight into the topic. Here we report the latest 
research evidence on the possible oxidation-related 
regulatory mechanisms of TH expression. 
 Intracellular Zn
2+
 is involved in facilitating physiological 
processes. This essential transition element is contained in 
structural or functional domains of several proteins, 
including enzymes necessary for replication, transcription 
and translation, cell division and differentiation [95]. 
Depending upon its concentration, Zn
2+
 may be 
neuroprotective or neurotoxic by means of its antioxidant 
and pro-oxidant properties. Excess of intracellular Zn
2+
 or 
long-term exposure to Zn
2+
 induces DA-ergic 
neurodegeneration in rats [40, 96, 97]. Furthermore, high 
levels of Zn
2+
 are associated with neurodegenerative 
diseases, including Alzheimer’s disease and PD [98, 99]. 
Recent studies have provided further insights in the 
mechanisms of DA-ergic neurodegeneration induced by high 
levels of Zn
2+
. In particular, Kumar et al. [40] have shown 
that Zn
2+
-mediated DA neuron loss is related to an increased 
lipoxygenase, superoxide dismutase, heme oxygenase-1 and 
decreased catalase, and glutathione-S-transferase activities 
and TH expression. 
 Changes in cellular redox status can directly or indirectly 
affect pathways for the regulation of gene expression. 
Reductive or oxidative stresses can modulate the 
transcription of certain genes by pathways that probably 
involve protein kinases [100-103]. Additionally, the cellular 
response to severe oxidative conditions may affect, through 
the oxidation or alkylation of thiol residues, the binding 
mechanisms of nucleic acid regulatory factors, which can be 
directly activated or inactivated. 
 Zinc finger proteins constitute the main cellular DNA-
regulatory system [104, 105]. They all contain redox 
regulation cysteine residues as part of the metal-binding, 
DNA-intercalating fingers [106, 107]. The zinc finger 
domain of these proteins binds with different affinities to 
specific nucleotidic sequences (e.g. TATA or CAAT box 
elements) in proximal promoter sites of genes and it 
contributes to the transcriptional regulation of numerous 
genes, including the TH gene [108-110]. Some of these 
transcription factors appear to become progressively 
oxidized during aging, resulting in the reversible loss of 
binding activity [111]. It has been hypothesized that Cys 
residues may constitute redox switches which directly 
regulate gene expression [112, 113]. 
 DJ-1(PARK7) is a multifunctional protein, and loss of its 
functions or expression is thought to be responsible for onset 
of familial and sporadic PD [114, 115]. Mutations and 
increased ubiquitin-proteasome system degradation of DJ-1 
have been described in patients with familial PD [116, 117] 
and in experimental models of PD [118]. DJ-1 belongs to the 
peptidase C56 family of proteins. It acts as a positive co-
activator of various transcription factors regulating 
expression of several genes, including TH by means of its 
interaction with the metastasis associated protein 1 co-
regulator [119]. It may also function as a redox-sensitive 
chaperone, as a sensor for oxidative stress, and it apparently 
protects neurons against oxidative stress and cell death. 
 Cys residues of DJ-1 (Cys-46, Cys-53, and Cys-106)are 
oxidized during cellular oxidative stress, resulting in 
scavenging of ROS [120-122] and in the functional response 
of the protein. The anti-oxidant function of DJ-1 might 
therefore be routed by self-oxidation of Cys residues and by 
activation of redox-related genes. The transcription 
repressor, PTB-associated splicing factor (PSF), has a 
specific binding site on the TH gene promoter. It has been 
reported that human DJ-1 binds to PSF to sequester the 
PSF/co-repressor complex, leading to induction of TH gene 
expression [123]. Studies aimed to evaluate the protective 
mechanisms of DJ-1 have shown that nigral injection of DJ-
1 restored DA metabolism in 6-hydroxydopamine-treated 
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animals by binding directly to TH and L-dopa decarboxylase 
in a manner dependent on the oxidative state of Cys-106, 
thereby stimulating their activities. Taken together, these 
findings indicate DJ-1 as a extra-neuronal essential factor in 
the redox-dependent regulation of TH expression and 
activity and the consequent DA homeostasis, which is 
crucial to the pathogenesis of DA-linked neurodegenerative 
disease. 
CONCLUSIONS 
 DA cells possess a distinct physiology intrinsically 
associated with elevated ROS production, and selectively 
degenerate under oxidative stress conditions. Increased free 
radical production, mitochondrial dysfunction and impaired 
antioxidant defences system are, therefore, the key players 
contributing to DA-ergic-linked neurological disorders. 
 In the last decades several studies of extreme interest 
have been conducted to provide further insights in the 
intracellular redox-related pathogenic mechanisms in DA 
neurons. The key role of TH function in maintaining the 
physiological levels of DA in brain has prompted 
investigators to investigate the possible implications of 
oxidative stress in the dysfunctions of this enzyme during 
DA neurodegeneration. TH is a promising drug target for 
these diseases, but no structural information is currently 
available to assist in drug development. Furthermore, the 
redox mechanisms that modulate TH activity, metabolism 
and expression (Fig. 4) are not well understood, although an 
increasing number of scientific contributions are focusing on 
the biological relevance of this phenomenon. 
 The aim of this review has been, therefore, to provide an 
overview of this under explored research field and further 
crucial information for understanding the redox-mediated 
mechanisms in healthy and diseased brain. 
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BH4 = Tetrahydrobiopterin 
CAs = Catecholamines 
Cys = Cysteine 
DA = Dopamine 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4). Schematic summary of oxidation-mediated TH activity, metabolism and expression alterations. An intracellular oxidative 
environment affects the phosphorylated status of TH by thiol oxidation, carbonylation, nitration and S-thyolation of cysteine residues in the 
enzyme. This results in inhibition of TH activity and increased degradation rate of TH. Oxidative stress can also affect negatively TH gene 
expression by mediating a functional impairment of the zinc-finger DNA-regulating proteins and the transcription factor DJ-1. Reduction of 
TH activity, increased TH degradation and TH gene down-regulation might represent critical phenomena leading to DA-ergic dysfunction. 
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L-DOPA = L-3,4-dihydroxyphenylalanine 
ERK 1/2 = Extracellular regulated kinase 1/2 
GSH = Reduceed glutathionine 
PD = Parkinson’s disease 
ONOO
-
 = Peroxynitrite 
PD = Parkinson’s disease 
PSF = PTB-associated splicing factor 
ROS = Reactive oxygen species 
Ser = Serine 
SNc = Substantia nigra pars compacta 
TH = Tyrosine hydroxylase 
TPH = Tryptophan hydroxylase 
REFERENCES 
[1] Shacter, E. Quantification and significance of protein oxidation in 
biological samples. Drug Metab. Rev., 2000, 32(3-4), 307-326. 
[2] Jones, D.P.; Go, Y.M.; Anderson, C.L.; Ziegler, T.R.; Kinkade, 
J.M., Jr.; Kirlin, W.G. Cysteine/cystine couple is a newly 
recognized node in the circuitry for biologic redox signaling and 
control. FASEB J., 2004, 18(11), 1246-1248. 
[3] Schafer, F.Q.; Buettner, G.R. Redox environment of the cell as 
viewed through the redox state of the glutathione 
disulfide/glutathione couple. Free Radic. Biol. Med., 2001, 30(11), 
1191-1212. 
[4] Bader, M.; Muse, W.; Ballou, D.P.; Gassner, C.; Bardwell, J.C. 
Oxidative protein folding is driven by the electron transport system. 
Cell, 1999, 98(2), 217-227. 
[5] Paget, M.S.; Buttner, M.J. Thiol-based regulatory switches. Ann. 
Rev. Genet., 2003, 37, 91-121. 
[6] Stadtman, E.R. Protein oxidation in aging and age-related diseases. 
Ann. NY Acad. Sci., 2001, 928, 22-38. 
[7] Wong-Ekkabut, J.; Xu, Z.; Triampo, W.; Tang, I.M.; Tieleman, 
D.P.; Monticelli, L. Effect of lipid peroxidation on the properties of 
lipid bilayers: a molecular dynamics study. Biophys. J., 2007, 
93(12), 4225-4236. 
[8] Halliwell, B. Antioxidant defence mechanisms: from the beginning 
to the end (of the beginning). Free Radic. Res., 1999, 31(4), 261-
272. 
[9] Mariani, E.; Polidori, M.C.; Cherubini, A.; Mecocci, P. Oxidative 
stress in brain aging, neurodegenerative and vascular diseases: an 
overview. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 
2005, 827(1), 65-75. 
[10] Jellinger, K.A. General aspects of neurodegeneration. J. Neural 
Transm. Suppl., 2003, 65, 101-144. 
[11] Migliore, L.; Fontana, I.; Colognato, R.; Coppede, F.; Siciliano, G.; 
Murri, L. Searching for the role and the most suitable biomarkers 
of oxidative stress in Alzheimer's disease and in other 
neurodegenerative diseases. Neurobiol. Aging, 2005, 26(5), 587-
595. 
[12] Perry, G.; Nunomura, A.; Hirai, K.; Zhu, X.; Perez, M.; Avila, J.; 
Castellani, R.J.; Atwood, C.S.; Aliev, G.; Sayre, L.M.; Takeda, A.; 
Smith, M.A. Is oxidative damage the fundamental pathogenic 
mechanism of Alzheimer's and other neurodegenerative diseases? 
Free Radic. Biol. Med., 2002, 33(11), 1475-1479. 
[13] Ashrafi, M.R.; Shams, S.; Nouri, M.; Mohseni, M.; Shabanian, R.; 
Yekaninejad, M.S.; Chegini, N.; Khodadad, A.; Safaralizadeh, R. A 
probable causative factor for an old problem: selenium and 
glutathione peroxidase appear to play important roles in epilepsy 
pathogenesis. Epilepsia, 2007, 48(9), 1750-1755. 
[14] Di Maio, R.; Mastroberardino, P.G.; Hu, X.; Montero, L.; 
Greenamyre, J.T. Pilocapine alters NMDA receptor expression and 
function in hippocampal neurons: NADPH oxidase and ERK1/2 
mechanisms. Neurobiol. Dis., 2011, 42(3), 482-495. 
[15] Esposito, E.; Di Matteo, V.; Di Giovanni, G. Death in the 
substantia nigra: a motor tragedy. Expert Rev. Neurother., 2007, 
7(6), 677-697. 
[16] Rinne, J.O. Nigral degeneration in Parkinson's disease. Mov. 
Disord. 1993, 8(Suppl 1), S31-S35. 
[17] Bjorklund, A.; Dunnett, S.B. Dopamine neuron systems in the 
brain: an update. Trends Neurosci., 2007, 30(5), 194-202. 
[18] Bonci, A.; Grillner, P.; Mercuri, N.B.; Bernardi, G. L-Type calcium 
channels mediate a slow excitatory synaptic transmission in rat 
midbrain dopaminergic neurons. J. Neurosci., 1998, 18(17), 6693-
6703. 
[19] Nedergaard, S.; Flatman, J.A.; Engberg, I. Nifedipine- and omega-
conotoxin-sensitive Ca2+ conductances in guinea-pig substantia 
nigra pars compacta neurones. J. Physiol., 1993, 466, 727-747. 
[20] Puopolo, M.; Raviola, E.; Bean, B.P. Roles of subthreshold calcium 
current and sodium current in spontaneous firing of mouse 
midbrain dopamine neurons. J. Neurosci., 2007, 27(3), 645-656. 
[21] Chan, C.S.; Gertler, T.S.; Surmeier, D.J. A molecular basis for the 
increased vulnerability of substantia nigra dopamine neurons in 
aging and Parkinson's disease. Mov. Disord., 2010, 25(Suppl 1), 
S63-S70. 
[22] Chan, C.S.; Guzman, J.N.; Ilijic, E.; Mercer, J.N.; Rick, C.; Tkatch, 
T.; Meredith, G.E.; Surmeier, D.J. 'Rejuvenation' protects neurons 
in mouse models of Parkinson's disease. Nature, 2007, 447(7148), 
1081-1086. 
[23] Jenner, P.; Olanow, C.W. Oxidative stress and the pathogenesis of 
Parkinson's disease. Neurology, 1996, 47(6 Suppl 3), S161-170. 
[24] Betarbet, R.; Sherer, T.B.; MacKenzie, G.; Garcia-Osuna, M.; 
Panov, A.V.; Greenamyre, J.T. Chronic systemic pesticide 
exposure reproduces features of Parkinson's disease. Nat. 
Neurosci., 2000, 3(12), 1301-1306. 
[25] McCormack, A.L.; Thiruchelvam, M.; Manning-Bog, A.B.; 
Thiffault, C.; Langston, J.W.; Cory-Slechta, D.A.; Di Monte, D.A. 
Environmental risk factors and Parkinson's disease: selective 
degeneration of nigral dopaminergic neurons caused by the 
herbicide paraquat. Neurobiol. Dis., 2002, 10(2), 119-127. 
[26] Di Matteo, V.; Pierucci, M.; Di Giovanni, G.; Di Santo, A.; Poggi, 
A.; Benigno, A.; Esposito, E. Aspirin protects striatal dopaminergic 
neurons from neurotoxin-induced degeneration: an in vivo 
microdialysis study. Brain Res., 2006, 1095(1), 167-177. 
[27] Zigmond, R.E.; Schwarzschild, M.A.; Rittenhouse, A.R. Acute 
regulation of tyrosine hydroxylase by nerve activity and by 
neurotransmitters via phosphorylation. Ann. Rev. Neurosci., 1989, 
12, 415-461. 
[28] Haycock, J.W. Phosphorylation of tyrosine hydroxylase in situ at 
serine 8, 19, 31, and 40. J. Biol. Chem., 1990, 265(20), 11682-
11691. 
[29] Fitzpatrick, P.F. Tetrahydropterin-dependent amino acid 
hydroxylases. Ann. Rev., Biochem., 1999, 68, 355-381. 
[30] Kumer, S.C.; Vrana, K.E. Intricate regulation of tyrosine 
hydroxylase activity and gene expression. J. Neurochem., 1996, 
67(2), 443-462. 
[31] Ischiropoulos, H. Biological selectivity and functional aspects of 
protein tyrosine nitration. Biochem. Biophys. Res. Commun., 2003, 
305(3), 776-783. 
[32] Good, P.F.; Hsu, A.; Werner, P.; Perl, D.P.; Olanow, C.W. Protein 
nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol., 
1998, 57(4), 338-342. 
[33] Torreilles, F.; Salman-Tabcheh, S.; Guerin, M.; Torreilles, J. 
Neurodegenerative disorders: the role of peroxynitrite. Brain Res. 
Brain Res. Rev., 1999, 30(2), 153-163. 
[34] Ara, J.; Przedborski, S.; Naini, A.B.; Jackson-Lewis, V.; Trifiletti, 
R.R.; Horwitz, J.; Ischiropoulos, H. Inactivation of tyrosine 
hydroxylase by nitration following exposure to peroxynitrite and 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc. Natl. 
Acad. Sci. USA, 1998, 95(13), 7659-7663. 
[35] Blanchard-Fillion, B.; Souza, J.M.; Friel, T.; Jiang, G.C.; Vrana, 
K.; Sharov, V.; Barron, L.; Schoneich, C.; Quijano, C.; Alvarez, B.; 
Radi, R.; Przedborski, S.; Fernando, G.S.; Horwitz, J.; 
Ischiropoulos, H. Nitration and inactivation of tyrosine hydroxylase 
by peroxynitrite. J. Biol. Chem., 2001, 276(49), 46017-46023. 
[36] Sadidi, M.; Geddes, T.J.; Kuhn, D.M. S-thiolation of tyrosine 
hydroxylase by reactive nitrogen species in the presence of cysteine 
or glutathione. Antioxid. Redox Signal., 2005, 7(7-8), 863-869. 
[37] Dunkley, P.R.; Bobrovskaya, L.; Graham, M.E.; von Nagy-
Felsobuki, E.I.; Dickson, P.W. Tyrosine hydroxylase 
phosphorylation: regulation and consequences. J. Neurochem., 
2004, 91(5), 1025-1043. 
Redox Sensitivity of Tyrosine Hydroxylase Activity and Expression CNS & Neurological Disorders - Drug Targets, 2012, Vol. 11, No. 4     427 
[38] Chetsawang, B.; Chetsawang, J.; Govitrapong, P. Protection 
against cell death and sustained tyrosine hydroxylase 
phosphorylation in hydrogen peroxide- and MPP-treated human 
neuroblastoma cells with melatonin. J. Pineal Res., 2009, 46(1), 
36-42. 
[39] Klongpanichapak, S.; Phansuwan-Pujito, P.; Ebadi, M.; 
Govitrapong, P. Melatonin inhibits amphetamine-induced increase 
in alpha-synuclein and decrease in phosphorylated tyrosine 
hydroxylase in SK-N-SH cells. Neurosci. Lett., 2008, 436(3), 309-
313. 
[40] Singh, B.K.; Kumar, A.; Ahmad, I.; Kumar, V.; Patel, D.K.; Jain, 
S.K.; Singh, C. Oxidative stress in zinc-induced dopaminergic 
neurodegeneration: implications of superoxide dismutase and heme 
oxygenase-1. Free Radic. Res., 2011, 45(10), 1207-1222. 
[41] Ishikawa, S.; Taira, T.; Niki, T.; Takahashi-Niki, K.; Maita, C.; 
Maita, H.; Ariga, H.; Iguchi-Ariga, S.M. Oxidative status of DJ-1-
dependent activation of dopamine synthesis through interaction of 
tyrosine hydroxylase and 4-dihydroxy-L-phenylalanine (L-DOPA) 
decarboxylase with DJ-1. J. Biol. Chem., 2009, 284(42), 28832-
28844. 
[42] MohanKumar, S.M.; Kasturi, B.S.; Shin, A.C.; Balasubramanian, 
P.; Gilbreath, E.T.; Subramanian, M.; Mohankumar, P.S. Chronic 
estradiol exposure induces oxidative stress in the hypothalamus to 
decrease hypothalamic dopamine and cause hyperprolactinemia. 
Am. J. Physiol. Regul. Integr. Comp. Physiol., 2010, 300(3), R693-
R699. 
[43] Jenner, P. Oxidative stress in Parkinson's disease. Ann. Neurol., 
2003, 53(Suppl 3), S26-S36; discussion S36-S38. 
[44] Horowitz, M.P.; Milanese, C.; Di Maio, R.; Hu, X.; Montero, L.M.; 
Sanders, L.H.; Tapias, V.; Sepe, S.; van Cappellen, W.A.; Burton, 
E.A.; Greenamyre, J.T.; Mastroberardino, P.G. Single-cell redox 
imaging demonstrates a distinctive response of dopaminergic 
neurons to oxidative insults. Antioxid. Redox Signal., 2011, 15(4), 
855-871. 
[45] Bodhinathan, K.; Kumar, A.; Foster, T.C. Intracellular redox state 
alters NMDA receptor response during aging through 
Ca2+/calmodulin-dependent protein kinase II. J. Neurosci., 2010, 
30(5), 1914-1924. 
[46] Cai, S.Q.; Sesti, F. Oxidation of a potassium channel causes 
progressive sensory function loss during aging. Nat. Neurosci., 
2009, 12(5), 611-617. 
[47] Gamper, N.; Zaika, O.; Li, Y.; Martin, P.; Hernandez, C.C.; Perez, 
M.R.; Wang, A.Y.; Jaffe, D.B.; Shapiro, M.S. Oxidative 
modification of M-type K(+) channels as a mechanism of 
cytoprotective neuronal silencing. EMBO J., 2006, 25(20), 4996-
5004. 
[48] Wu, X.; Bishopric, N.H.; Discher, D.J.; Murphy, B.J.; Webster, 
K.A. Physical and functional sensitivity of zinc finger transcription 
factors to redox change. Mol. Cell Biol., 1996, 16(3), 1035-1046. 
[49] Mastroberardino, P.G.; Hoffman, E.K.; Horowitz, M.P.; Betarbet, 
R.; Taylor, G.; Cheng, D.; Na, H.M.; Gutekunst, C.A.; Gearing, 
M.; Trojanowski, J.Q.; Anderson, M.; Chu, C.T.; Peng, J.; 
Greenamyre, J.T. A novel transferrin/TfR2-mediated mitochondrial 
iron transport system is disrupted in Parkinson's disease. Neurobiol. 
Dis., 2009, 34(3), 417-431. 
[50] Adimora, N.J.; Jones, D.P.; Kemp, M.L. A model of redox kinetics 
implicates the thiol proteome in cellular hydrogen peroxide 
responses. Antioxid. Redox Signal., 2010, 13(6), 731-743. 
[51] Kemp, M.; Go, Y.M.; Jones, D.P. Nonequilibrium thermodynamics 
of thiol/disulfide redox systems: a perspective on redox systems 
biology. Free Radic. Biol. Med., 2008, 44(6), 921-937. 
[52] Yang, W.; Tiffany-Castiglioni, E. The bipyridyl herbicide paraquat 
produces oxidative stress-mediated toxicity in human 
neuroblastoma SH-SY5Y cells: relevance to the dopaminergic 
pathogenesis. J. Toxicol. Environ. Health A, 2005, 68(22), 1939-
1961. 
[53] Sherer, T.B.; Betarbet, R.; Testa, C.M.; Seo, B.B.; Richardson, 
J.R.; Kim, J.H.; Miller, G.W.; Yagi, T.; Matsuno-Yagi, A.; 
Greenamyre, J.T. Mechanism of toxicity in rotenone models of 
Parkinson's disease. J. Neurosci., 2003, 23(34), 10756-10764. 
[54] Hawkins, C.L.; Davies, M.J. Generation and propagation of radical 
reactions on proteins. Biochim. Biophys. Acta, 2001, 1504(2-3), 
196-219. 
[55] Stadtman, E.R.; Berlett, B.S. Reactive oxygen-mediated protein 
oxidation in aging and disease. Chem. Res. Toxicol., 1997, 10(5), 
485-494. 
[56] Stadtman, E.R.; Oliver, C.N. Metal-catalyzed oxidation of proteins. 
Physiological consequences. J. Biol. Chem., 1991, 266(4), 2005-
2008. 
[57] He, Y.; Imam, S.Z.; Dong, Z.; Jankovic, J.; Ali, S.F.; Appel, S.H.; 
Le, W. Role of nitric oxide in rotenone-induced nigro-striatal 
injury. J. Neurochem., 2003, 86(6), 1338-1345. 
[58] Haavik, J.; Flatmark, T. Isolation and characterization of 
tetrahydropterin oxidation products generated in the tyrosine 3-
monooxygenase (tyrosine hydroxylase) reaction. Eur. J. Biochem., 
1987, 168(1), 21-26. 
[59] Ramsey, A.J.; Fitzpatrick, P.F. Effects of phosphorylation of serine 
40 of tyrosine hydroxylase on binding of catecholamines: evidence 
for a novel regulatory mechanism. Biochemistry, 1998, 37(25), 
8980-8986. 
[60] Ramsey, A.J.; Fitzpatrick, P.F. Effects of phosphorylation on 
binding of catecholamines to tyrosine hydroxylase: specificity and 
thermodynamics. Biochemistry, 2000, 39(4), 773-778. 
[61] Barbosa, E.R.; Comerlatti, L.R.; Haddad, M.S.; Scaff, M. 
[Parkinsonism secondary to ethylene oxide exposure: case report. 
Arq. Neuropsiquiatr., 1992, 50(4), 531-533. 
[62] Muller-Vahl, K.R.; Kolbe, H.; Dengler, R. Transient severe 
parkinsonism after acute organophosphate poisoning. J. Neurol. 
Neurosurg. Psychiatry, 1999, 66(2), 253-254. 
[63] De La Cruz, C.P.; Revilla, E.; Venero, J.L.; Ayala, A.; Cano, J.; 
Machado, A. Oxidative inactivation of tyrosine hydroxylase in 
substantia nigra of aged rat. Free Radic. Biol. Med., 1996, 20(1), 
53-61. 
[64] Wallace, D.C. Bioenergetic Origins of Complexity and Disease. 
Cold Spring Harb. Symp. Quant. Biol., 2011, [Epub ahead of print]. 
[65] Borges, C.R.; Geddes, T.; Watson, J.T.; Kuhn, D.M. Dopamine 
biosynthesis is regulated by S-glutathionylation. Potential 
mechanism of tyrosine hydroxylast inhibition during oxidative 
stress. J. Biol. Chem., 2002, 277(50), 48295-48302. 
[66] Park, S.; Geddes, T.J.; Javitch, J.A.; Kuhn, D.M. Dopamine 
prevents nitration of tyrosine hydroxylase by peroxynitrite and 
nitrogen dioxide: is nitrotyrosine formation an early step in 
dopamine neuronal damage? J. Biol. Chem., 2003, 278(31), 28736-
28742. 
[67] Klatt, P.; Lamas, S. Regulation of protein function by S-
glutathiolation in response to oxidative and nitrosative stress. Eur. 
J. Biochem., 2000, 267(16), 4928-4944. 
[68] Kuhn, D.M.; Geddes, T.J. Tetrahydrobiopterin prevents nitration of 
tyrosine hydroxylase by peroxynitrite and nitrogen dioxide. Mol. 
Pharmacol., 2003, 64(4), 946-953. 
[69] Kuhn, D.M.; Geddes, T.J. Reduced nicotinamide nucleotides 
prevent nitration of tyrosine hydroxylase by peroxynitrite. Brain 
Res., 2002, 933(1), 85-89. 
[70] Kuhn, D.M.; Sakowski, S.A.; Sadidi, M.; Geddes, T.J. 
Nitrotyrosine as a marker for peroxynitrite-induced neurotoxicity: 
the beginning or the end of the end of dopamine neurons? J. 
Neurochem., 2004, 89(3), 529-536. 
[71] Franco, J.L.; Posser, T.; Gordon, S.L.; Bobrovskaya, L.; Schneider, 
J.J.; Farina, M.; Dafre, A.L.; Dickson, P.W.; Dunkley, P.R. 
Expression of tyrosine hydroxylase increases the resistance of 
human neuroblastoma cells to oxidative insults. Toxicol. Sci., 2009, 
113(1), 150-157. 
[72] Kaushik, P.; Gorin, F.; Vali, S. Dynamics of tyrosine hydroxylase 
mediated regulation of dopamine synthesis. J. Comput. Neurosci., 
2007, 22(2), 147-160. 
[73] Moy, L.Y.; Tsai, L.H. Cyclin-dependent kinase 5 phosphorylates 
serine 31 of tyrosine hydroxylase and regulates its stability. J. Biol. 
Chem., 2004, 279(52), 54487-54493. 
[74] Iida, Y.; Sawabe, K.; Kojima, M.; Oguro, K.; Nakanishi, N.; 
Hasegawa, H. Proteasome-driven turnover of tryptophan 
hydroxylase is triggered by phosphorylation in RBL2H3 cells, a 
serotonin producing mast cell line. Eur. J. Biochem., 2002, 
269(19), 4780-4788. 
[75] Kawahata, I.; Tokuoka, H.; Parvez, H.; Ichinose, H. Accumulation 
of phosphorylated tyrosine hydroxylase into insoluble protein 
aggregates by inhibition of an ubiquitin-proteasome system in 
PC12D cells. J. Neural Transm., 2009, 116(12), 1571-1578. 
[76] Winterbourn, C.C.; Hampton, M.B. Thiol chemistry and specificity 
in redox signaling. Free Radic. Biol. Med., 2008, 45(5), 549-561. 
[77] McCubrey, J.A.; Franklin, R.A. Reactive oxygen intermediates and 
signaling through kinase pathways. Antioxid. Redox Signal., 2006, 
8(9-10), 1745-1748. 
428      CNS & Neurological Disorders - Drug Targets, 2012, Vol. 11, No. 4 Di Giovanni et al. 
[78] Agnati, L.F.; Fuxe, K.; Benfenati, F.; Zini, I.; Zoli, M.; Fabbri, L.; 
Harfstrand, A. Computer-assisted morphometry and 
microdensitometry of transmitter- identified neurons with special 
reference to the mesostriatal dopamine pathway. Methodological 
aspects. Acta Physiol. Scand. Suppl., 1984, 532, 5-36. 
[79] Finch, C.E.; Morgan, D.G. RNA and protein metabolism in the 
aging brain. Ann. Rev. Neurosci., 1990, 13, 75-88. 
[80] Venero, J.L.; Machado, A.; Cano, J. Changes in monoamines and 
their metabolite levels in substantia nigra of aged rats. Mech. 
Ageing Dev., 1989, 49(3), 227-233. 
[81] Venero, J.L.; Machado, A.; Cano, J. Age effects on monoamine 
turnover of the rat substantia nigra. Brain Res., 1991, 557(1-2), 
109-114. 
[82] McGeer, P.L.; Itagaki, S.; Akiyama, H.; McGeer, E.G. Rate of cell 
death in parkinsonism indicates active neuropathological process. 
Ann. Neurol., 1988, 24(4), 574-576. 
[83] McGeer, P.L.; McGeer, E.G.; Suzuki, J.S. Aging and 
extrapyramidal function. Arch. Neurol., 1977, 34(1), 33-35. 
[84] Allen, E.; Carlson, K.M.; Zigmond, M.J.; Cavanaugh, J.E. L-
DOPA reverses motor deficits associated with normal aging in 
mice. Neurosci. Lett., 2010, 489(1), 1-4. 
[85] Anandhan, A.; Tamilselvam, K.; Radhiga, T.; Rao, S.; Essa, M.M.; 
Manivasagam, T. Theaflavin, a black tea polyphenol, protects 
nigral dopaminergic neurons against chronic MPTP/probenecid 
induced Parkinson's disease. Brain Res., 2011, 1433, 104-113. 
[86] Ahmad, S.; Khan, M.B.; Hoda, M.N.; Bhatia, K.; Haque, R.; Fazili, 
I.S.; Jamal, A.; Khan, J.S.; Katare, D.P. Neuroprotective Effect of 
Sesame Seed Oil in 6-Hydroxydopamine Induced Neurotoxicity in 
Mice Model: Cellular, Biochemical and Neurochemical Evidence. 
Neurochem. Res., 2011, 37(3), 516-526. 
[87] Huh, S.H.; Chung, Y.C.; Piao, Y.; Jin, M.Y.; Son, H.J.; Yoon, N.S.; 
Hong, J.Y.; Pak, Y.K.; Kim, Y.S.; Hong, J.K.; Hwang, O.; Jin, 
B.K. Ethyl pyruvate rescues nigrostriatal dopaminergic neurons by 
regulating glial activation in a mouse model of Parkinson's disease. 
J. Immunol., 2011, 187(2), 960-969. 
[88] Sai, Y.; Wu, Q.; Le, W.; Ye, F.; Li, Y.; Dong, Z. Rotenone-induced 
PC12 cell toxicity is caused by oxidative stress resulting from 
altered dopamine metabolism. Toxicol. In Vitro, 2008, 22(6), 1461-
1468. 
[89] Kim, Y.H.; Rane, A.; Lussier, S.; Andersen, J.K. Lithium protects 
against oxidative stress-mediated cell death in alpha-synuclein-
overexpressing in vitro and in vivo models of Parkinson's disease. 
J. Neurosci. Res., 2011, 89(10), 1666-1675. 
[90] Banerjee, U.; Dasgupta, A.; Rout, J.K.; Singh, O.P. Effects of 
lithium therapy on Na(+)-K(+)-ATPase activity and lipid 
peroxidation in bipolar disorder. Prog. Neuropsychopharmacol. 
Biol. Psychiatry, 2012, 37(1), 56-61. 
[91] Tan, H.; Young, L.T.; Shao, L.; Che, Y.; Honer, W.G.; Wang, J.F. 
Mood stabilizer lithium inhibits amphetamine-increased 4-
hydroxynonenal-protein adducts in rat frontal cortex. Int. J. 
Neuropsychopharmacol., 2011, [Epub ahead of print] 
[92] Brandish, P.E.; Su, M.; Holder, D.J.; Hodor, P.; Szumiloski, J.; 
Kleinhanz, R.R.; Forbes, J.E.; McWhorter, M.E.; Duenwald, S.J.; 
Parrish, M.L.; Na, S.; Liu, Y.; Phillips, R.L.; Renger, J.J.; 
Sankaranarayanan, S.; Simon, A.J.; Scolnick, E.M. Regulation of 
gene expression by lithium and depletion of inositol in slices of 
adult rat cortex. Neuron, 2005, 45(6), 861-872. 
[93] Willing, A.E.; Zigova, T.; Milliken, M.; Poulos, S.; Saporta, S.; 
McGrogan, M.; Snable, G.; Sanberg, P.R. Lithium exposure 
enhances survival of NT2N cells(hNT neurons) in the 
hemiparkinsonian rat. Eur. J. Neurosci., 2002, 16(12), 2271-2278. 
[94] Ferrie, L.; Young, A.H.; McQuade, R. Effect of lithium and lithium 
withdrawal on potassium-evoked dopamine release and tyrosine 
hydroxylase expression in the rat. Int. J. Neuropsychopharmacol., 
2006, 9(6), 729-735. 
[95] Takeda, A. Movement of zinc and its functional significance in the 
brain. Brain Res. Brain Res. Rev., 2000, 34(3), 137-148. 
[96] Kumar, A.; Ahmad, I.; Shukla, S.; Singh, B.K.; Patel, D.K.; 
Pandey, H.P.; Singh, C. Effect of zinc and paraquat co-exposure on 
neurodegeneration: Modulation of oxidative stress and expression 
of metallothioneins, toxicant responsive and transporter genes in 
rats. Free Radic. Res., 2010, 44(8), 950-965. 
[97] Kumar, A.; Singh, B.K.; Ahmad, I.; Shukla, S.; Patel, D.K.; 
Srivastava, G.; Kumar, V.; Pandey, H.P.; Singh, C. Involvement of 
NADPH oxidase and glutathione in zinc-induced dopaminergic 
neurodegeneration in rats: Similarity with paraquat neurotoxicity. 
Brain Res., 2011, 1438, 48-64. 
[98] Dexter, D.T.; Carayon, A.; Javoy-Agid, F.; Agid, Y.; Wells, F.R.; 
Daniel, S.E.; Lees, A.J.; Jenner, P.; Marsden, C.D. Alterations in 
the levels of iron, ferritin and other trace metals in Parkinson's 
disease and other neurodegenerative diseases affecting the basal 
ganglia. Brain, 1991, 114(Pt 4), 1953-1975. 
[99] Lin, A.M.; Fan, S.F.; Yang, D.M.; Hsu, L.L.; Yang, C.H. Zinc-
induced apoptosis in substantia nigra of rat brain: neuroprotection 
by vitamin D3. Free Radic. Biol. Med., 2003, 34(11), 1416-1425. 
[100] Webster, K.A.; Discher, D.J.; Bishopric, N.H. Induction and 
nuclear accumulation of fos and jun proto-oncogenes in hypoxic 
cardiac myocytes. J. Biol. Chem., 1993, 268(22), 16852-16858. 
[101] Bauskin, A.R.; Alkalay, I.; Ben-Neriah, Y. Redox regulation of a 
protein tyrosine kinase in the endoplasmic reticulum. Cell, 1991, 
66(4), 685-696. 
[102] Cowan, D.B.; Weisel, R.D.; Williams, W.G.; Mickle, D.A. The 
regulation of glutathione peroxidase gene expression by oxygen 
tension in cultured human cardiomyocytes. J. Mol. Cell Cardiol., 
1992, 24(4), 423-433. 
[103] Wang, G.L.; Semenza, G.L. General involvement of hypoxia-
inducible factor 1 in transcriptional response to hypoxia. Proc. 
Natl. Acad. Sci. USA, 1993, 90(9), 4304-4308. 
[104] Rhodes, D.; Klug, A. Zinc fingers. Sci. Am., 1993, 268(2), 56-59. 
[105] Berg, J.M. Sp1 and the subfamily of zinc finger proteins with 
guanine-rich binding sites. Proc. Natl. Acad. Sci. USA, 1992, 
89(23), 11109-11110. 
[106] Desjarlais, J.R.; Berg, J.M. Toward rules relating zinc finger 
protein sequences and DNA binding site preferences. Proc. Natl. 
Acad. Sci. USA, 1992, 89(16), 7345-7349. 
[107] Kadonaga, J.T.; Carner, K.R.; Masiarz, F.R.; Tjian, R. Isolation of 
cDNA encoding transcription factor Sp1 and functional analysis of 
the DNA binding domain. Cell, 1987, 51(6), 1079-1090. 
[108] Gill, G.; Pascal, E.; Tseng, Z.H.; Tjian, R. A glutamine-rich 
hydrophobic patch in transcription factor Sp1 contacts the 
dTAFII110 component of the Drosophila TFIID complex and 
mediates transcriptional activation. Proc. Natl. Acad. Sci. USA, 
1994, 91(1), 192-196. 
[109] Kim, S.J.; Onwuta, U.S.; Lee, Y.I.; Li, R.; Botchan, M.R.; Robbins, 
P.D. The retinoblastoma gene product regulates Sp1-mediated 
transcription. Mol. Cell Biol., 1992, 12(6), 2455-2463. 
[110] Kingsley, C.; Winoto, A. Cloning of GT box-binding proteins: a 
novel Sp1 multigene family regulating T-cell receptor gene 
expression. Mol. Cell. Biol., 1992, 12(10), 4251-4261. 
[111] Ammendola, R.; Mesuraca, M.; Russo, T.; Cimino, F. The DNA-
binding efficiency of Sp1 is affected by redox changes. Eur. J. 
Biochem., 1994, 225(1), 483-489. 
[112] Hentze, M.W.; Rouault, T.A.; Harford, J.B.; Klausner, R.D. 
Oxidation-reduction and the molecular mechanism of a regulatory 
RNA-protein interaction. Science, 1989, 244(4902), 357-359. 
[113] Pognonec, P.; Kato, H.; Roeder, R.G. The helix-loop-helix/leucine 
repeat transcription factor USF can be functionally regulated in a 
redox-dependent manner. J. Biol. Chem., 1992, 267(34), 24563-
24567. 
[114] Cookson, M.R. Pathways to Parkinsonism. Neuron, 2003, 37(1), 7-
10. 
[115] Bonifati, V.; Rizzu, P.; van Baren, M.J.; Schaap, O.; Breedveld, 
G.J.; Krieger, E.; Dekker, M.C.; Squitieri, F.; Ibanez, P.; Joosse, 
M.; van Dongen, J.W.; Vanacore, N.; van Swieten, J.C.; Brice, A.; 
Meco, G.; van Duijn, C.M.; Oostra, B.A.; Heutink, P. Mutations in 
the DJ-1 gene associated with autosomal recessive early-onset 
parkinsonism. Science, 2003, 299(5604), 256-259. 
[116] Annesi, G.; Savettieri, G.; Pugliese, P.; D'Amelio, M.; Tarantino, 
P.; Ragonese, P.; La Bella, V.; Piccoli, T.; Civitelli, D.; Annesi, F.; 
Fierro, B.; Piccoli, F.; Arabia, G.; Caracciolo, M.; Ciro Candiano, 
I.C.; Quattrone, A. DJ-1 mutations and parkinsonism-dementia-
amyotrophic lateral sclerosis complex. Ann. Neurol., 2005, 58(5), 
803-807. 
[117] Abou-Sleiman, P.M.; Healy, D.G.; Quinn, N.; Lees, A.J.; Wood, 
N.W. The role of pathogenic DJ-1 mutations in Parkinson's disease. 
Ann. Neurol., 2003, 54(3), 283-286. 
[118] Miller, D.W.; Ahmad, R.; Hague, S.; Baptista, M.J.; Canet-Aviles, 
R.; McLendon, C.; Carter, D.M.; Zhu, P.P.; Stadler, J.; Chandran, 
J.; Klinefelter, G.R.; Blackstone, C.; Cookson, M.R. L166P mutant 
DJ-1, causative for recessive Parkinson's disease, is degraded 
Redox Sensitivity of Tyrosine Hydroxylase Activity and Expression CNS & Neurological Disorders - Drug Targets, 2012, Vol. 11, No. 4     429 
through the ubiquitin-proteasome system. J. Biol. Chem., 2003, 
278(38), 36588-36595. 
[119] Reddy, S.D.; Rayala, S.K.; Ohshiro, K.; Pakala, S.B.; Kobori, N.; 
Dash, P.; Yun, S.; Qin, J.; O'Malley, B.W.; Kumar, R. Multiple 
coregulatory control of tyrosine hydroxylase gene transcription. 
Proc. Natl. Acad. Sci. USA, 2011, 108(10), 4200-4205. 
[120] Taira, T.; Saito, Y.; Niki, T.; Iguchi-Ariga, S.M.; Takahashi, K.; 
Ariga, H. DJ-1 has a role in antioxidative stress to prevent cell 
death. EMBO Rep., 2004, 5(2), 213-218. 
[121] Yanagida, T.; Kitamura, Y.; Yamane, K.; Takahashi, K.; Takata, 
K.; Yanagisawa, D.; Yasui, H.; Taniguchi, T.; Taira, T.; Honda, T.; 
Ariga, H. Protection against oxidative stress-induced 
neurodegeneration by a modulator for DJ-1, the wild-type of 
familial Parkinson's disease-linked PARK7. J. Pharmacol. Sci., 
2009, 109(3), 463-468. 
[122] Yanagida, T.; Tsushima, J.; Kitamura, Y.; Yanagisawa, D.; Takata, 
K.; Shibaike, T.; Yamamoto, A.; Taniguchi, T.; Yasui, H.; Taira, 
T.; Morikawa, S.; Inubushi, T.; Tooyama, I.; Ariga, H. Oxidative 
stress induction of DJ-1 protein in reactive astrocytes scavenges 
free radicals and reduces cell injury. Oxid. Med. Cell Longev., 
2009, 2(1), 36-42. 
[123] Zhong, N.; Kim, C.Y.; Rizzu, P.; Geula, C.; Porter, D.R.; Pothos, 
E.N.; Squitieri, F.; Heutink, P.; Xu, J. DJ-1 transcriptionally up-
regulates the human tyrosine hydroxylase by inhibiting the 
sumoylation of pyrimidine tract-binding protein-associated splicing 
factor. J. Biol. Chem., 2006, 281(30), 20940-20948. 
 
 
Received: January 11, 2012 Revised: February 17, 2012 Accepted: February 29, 2012 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PMID: 22483306 
View publication stats
